BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16682954)

  • 1. 15-Lipoxygenase-2 gene regulation by its product 15-(S)-hydroxyeicosatetraenoic acid through a negative feedback mechanism that involves peroxisome proliferator-activated receptor gamma.
    Subbarayan V; Krieg P; Hsi LC; Kim J; Yang P; Sabichi AL; Llansa N; Mendoza G; Logothetis CJ; Newman RA; Lippman SM; Menter DG
    Oncogene; 2006 Sep; 25(44):6015-25. PubMed ID: 16682954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells.
    Shappell SB; Gupta RA; Manning S; Whitehead R; Boeglin WE; Schneider C; Case T; Price J; Jack GS; Wheeler TM; Matusik RJ; Brash AR; Dubois RN
    Cancer Res; 2001 Jan; 61(2):497-503. PubMed ID: 11212240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of peroxisome proliferator-activated receptor-γ by a 12/15-lipoxygenase product of arachidonic acid: a possible neuroprotective effect in the brain after experimental intracerebral hemorrhage.
    Xu R; Wang S; Li W; Liu Z; Tang J; Tang X
    J Neurosurg; 2017 Sep; 127(3):522-531. PubMed ID: 27739938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gamma tocopherol upregulates the expression of 15-S-HETE and induces growth arrest through a PPAR gamma-dependent mechanism in PC-3 human prostate cancer cells.
    Campbell SE; Musich PR; Whaley SG; Stimmel JB; Leesnitzer LM; Dessus-Babus S; Duffourc M; Stone W; Newman RA; Yang P; Krishnan K
    Nutr Cancer; 2009; 61(5):649-62. PubMed ID: 19838939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential peroxisome proliferator-activated receptor-gamma isoform expression and agonist effects in normal and malignant prostate cells.
    Subbarayan V; Sabichi AL; Kim J; Llansa N; Logothetis CJ; Lippman SM; Menter DG
    Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1710-6. PubMed ID: 15533897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antineoplastic effects of 15(S)-hydroxyeicosatetraenoic acid and 13-S-hydroxyoctadecadienoic acid in non-small cell lung cancer.
    Li MY; Yuan HL; Ko FW; Wu B; Long X; Du J; Wu J; Ng CS; Wan IY; Mok TS; Hui DS; Underwood MJ; Chen GG
    Cancer; 2015 Sep; 121 Suppl 17():3130-45. PubMed ID: 26331820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma.
    Shappell SB; Olson SJ; Hannah SE; Manning S; Roberts RL; Masumori N; Jisaka M; Boeglin WE; Vader V; Dave DS; Shook MF; Thomas TZ; Funk CD; Brash AR; Matusik RJ
    Cancer Res; 2003 May; 63(9):2256-67. PubMed ID: 12727848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme association with PPARgamma: evidence of a new role for 15-lipoxygenase type 2.
    Flores AM; Li L; McHugh NG; Aneskievich BJ
    Chem Biol Interact; 2005 Jan; 151(2):121-32. PubMed ID: 15698583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct effects of annexin A7 and p53 on arachidonate lipoxygenation in prostate cancer cells involve 5-lipoxygenase transcription.
    Torosyan Y; Dobi A; Naga S; Mezhevaya K; Glasman M; Norris C; Jiang G; Mueller G; Pollard H; Srivastava M
    Cancer Res; 2006 Oct; 66(19):9609-16. PubMed ID: 17018618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoxygenase-derived metabolites are regulators of peroxisome proliferator-activated receptor gamma-2 expression in human vascular smooth muscle cells.
    Limor R; Sharon O; Knoll E; Many A; Weisinger G; Stern N
    Am J Hypertens; 2008 Feb; 21(2):219-23. PubMed ID: 18202670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inverse relationship between 15-lipoxygenase-2 and PPAR-gamma gene expression in normal epithelia compared with tumor epithelia.
    Subbarayan V; Xu XC; Kim J; Yang P; Hoque A; Sabichi AL; Llansa N; Mendoza G; Logothetis CJ; Newman RA; Lippman SM; Menter DG
    Neoplasia; 2005 Mar; 7(3):280-93. PubMed ID: 15799828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor-gamma suppresses cyclooxygenase-2 expression in human prostate cells.
    Sabichi AL; Subbarayan V; Llansa N; Lippman SM; Menter DG
    Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1704-9. PubMed ID: 15533896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposing effects of 15-lipoxygenase-1 and -2 metabolites on MAPK signaling in prostate. Alteration in peroxisome proliferator-activated receptor gamma.
    Hsi LC; Wilson LC; Eling TE
    J Biol Chem; 2002 Oct; 277(43):40549-56. PubMed ID: 12189136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 8S-lipoxygenase products activate peroxisome proliferator-activated receptor alpha and induce differentiation in murine keratinocytes.
    Muga SJ; Thuillier P; Pavone A; Rundhaug JE; Boeglin WE; Jisaka M; Brash AR; Fischer SM
    Cell Growth Differ; 2000 Aug; 11(8):447-54. PubMed ID: 10965849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 13-Oxo-ODE is an endogenous ligand for PPARgamma in human colonic epithelial cells.
    Altmann R; Hausmann M; Spöttl T; Gruber M; Bull AW; Menzel K; Vogl D; Herfarth H; Schölmerich J; Falk W; Rogler G
    Biochem Pharmacol; 2007 Aug; 74(4):612-22. PubMed ID: 17604003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of PPARγ by 12/15-lipoxygenase during cerebral ischemia-reperfusion injury.
    Han J; Sun L; Xu Y; Liang H; Cheng Y
    Int J Mol Med; 2015 Jan; 35(1):195-201. PubMed ID: 25395029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double dioxygenation by mouse 8S-lipoxygenase: specific formation of a potent peroxisome proliferator-activated receptor alpha agonist.
    Jisaka M; Iwanaga C; Takahashi N; Goto T; Kawada T; Yamamoto T; Ikeda I; Nishimura K; Nagaya T; Fushiki T; Yokota K
    Biochem Biophys Res Commun; 2005 Dec; 338(1):136-43. PubMed ID: 16112079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor gamma regulates E-cadherin expression and inhibits growth and invasion of prostate cancer.
    Annicotte JS; Iankova I; Miard S; Fritz V; Sarruf D; Abella A; Berthe ML; Noël D; Pillon A; Iborra F; Dubus P; Maudelonde T; Culine S; Fajas L
    Mol Cell Biol; 2006 Oct; 26(20):7561-74. PubMed ID: 17015477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor gamma inhibits follicular and anaplastic thyroid carcinoma cells growth by upregulating p21Cip1/WAF1 gene in a Sp1-dependent manner.
    Bonofiglio D; Qi H; Gabriele S; Catalano S; Aquila S; Belmonte M; Andò S
    Endocr Relat Cancer; 2008 Jun; 15(2):545-57. PubMed ID: 18509005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor gamma in human prostate carcinoma.
    Nakamura Y; Suzuki T; Sugawara A; Arai Y; Sasano H
    Pathol Int; 2009 May; 59(5):288-93. PubMed ID: 19432669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.